Pancreatic neoplasms

1 paper

Trial sponsors

Novartis Pharmaceuticals Corporation
Company1 trialPhase 2160 people
Eli Lilly and Company
Company1 trialPhase 1/2540 people
M.D. Anderson Cancer Center
1 trialPhase 250 people
University of Iowa
1 trialPhase 240 people
Fudan University
1 trialPhase 230 people
Emory University
1 trialPhase 225 people
Washington University School of Medicine
3 trialsPhase 1/2101 people
National Cancer Institute
2 trialsPhase 1/2175 people

Latest

2 in 12 months

PLOS One9 Sep

Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study

Study protocolPopulations

Clinical and Experimental Medicine3 Sep

Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Meta-analysis of randomised trialsSGLT2 inhibitors